LINK . SPRINGER . COM {}

Matching Content Categories {📚}

• Science
• Education
• Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure if the website is profiting.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

nanocomplex, goamirpi, ferroptosis, fig, cells, goamiri, nanocomplexes, cell, tumor, goamirnc, lhpp, article, goa, pubmed, hcc, bel, treatment, goamir, expression, google, scholar, mirna, groups, cas, cancer, effects, control, size, mice, zhang, vivo, data, fluorescence, wang, therapy, potential, pathway, delivery, antitumor, gem, hepatocellular, carcinoma, treated, lipid, tissues, group, stability, china, chemotherapy, gpx,

Topics {✒️}

goa/fam-mir-nc nanocomplexes show alpha-fetoprotein-negative hepatocellular carcinoma nanoparticle-mediated pd-l1 inhibition goa/mir-765i nanocomplex demonstrated goa/mir-765i nanocomplexes show goa/mir-765i nanocomplexes exhibited goa/mir-765i nanocomplexes treatments goa/mir-363-5pi nanocomplex possesses traditional cancer-fighting techniques—shifting stabilized goa/mir-nc nanocomplex goa/fam-mir-nc nanocomplexes prepared goa/mir-nc nanocomplex goa/mir-nc nanocomplex prepared goa/mir-765i nanocomplexes serve goa/mir-nc nanocomplex solution cui-yun yu revised goa/mir-765i nanocomplex groups goa/mir-765i nanocomplex treatment goa/mir-nc nanocomplex groups goa/mir-765i nanocomplexes groups goa/mir-765i nanocomplexes compared ferroptosis-related circular rna microrna-1287-5p promotes ferroptosis carbon-coated copper grid galactosylated-chitosan-5-fluorouracil prodrug goa/mir-765i nanocomplex goa/mir nanocomplex displayed goa/mir-nc nanocomplex goa/mir-765i nanocomplexes effect-mediated passive targeting goa/cy5-mir nanocomplexes observed lipo/fam-mir-nc goa/ fam-mir-nc goa/mir nanocomplex occurs goa/mir-363-5pi nanocomplex goa/mir-353-5pi nanocomplex low-temperature annealing processes potent anti-hcc effects free fam-mir-nc trim21/eloa/lhpp axis time-dependent lysosomal escape stabilized goa/mir-363-5pi article download pdf goa/fam-mir uptake prepared goa/mir-nc vivo anti-tumor efficacy optimized goa/mir-363-5pi cui-yun yu vivo anti-tumor effects ferroptosis-based therapeutic strategies

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Histidine phosphatase-ferroptosis crosstalk modulation for efficient hepatocellular carcinoma treatment
         description:Altering the mechanisms of tumor cell death and overcoming the limitations of traditional chemotherapy is pivotal to contemporary tumor treatment. Inducing ferroptosis, while circumventing safety concerns associated with ferrous vectors, through nonferrous ferroptosis is a promising but underexplored frontier in cancer therapy. Histidine phosphatase (LHPP) has emerged as a novel therapeutic target in treating hepatocellular carcinoma (HCC), but the precise mechanism of LHPP against HCC remains unclear. Herein, we explore the effects of upregulating LHPP expression on ferroptosis and tumor immunogenicity induction by simply delivering a miRNA-363-5p inhibitor (miR-363-5pi) via a previously optimized gemcitabine-oleic acid (GOA) prodrug. Efficient miRNA encapsulation was achieved through hydrogen bonding at an optimized GOA/miRNA molar feed ratio of 250:1, affording spherical nanoparticles with a uniform hydrodynamic size of 147.1 nm and a negative potential of -21.5 mV. The mechanism of this LHPP-ferroptosis crosstalk is disclosed to be an inhibited phosphorylation of the PI3K/Akt pathway, leading to a remarkable tumor inhibition rate of 88.2% in nude mice bearing Bel-7402 tumor xenografts via a combination of LHPP-triggered nonferrous ferroptosis and GOA-induced chemotherapy. The biocompatibility of GOA/miR-363-5pi is strongly supported by their non-hematologic toxicity and insignificant organ damage. In addition, the tumor immunogenic activation potential of GOA/miR-363-5pi was finally explored. Overall, this study is the first work that elucidates the precise mechanism of LHPP for treating HCC via ferroptosis induction and achieves the transformation of chemotherapy and gene therapy into ferroptosis activation with tumor cell immunogenicity, which lays a new therapeutic foundation for the clinical treatment of HCC.
         datePublished:2024-10-15T00:00:00Z
         dateModified:2024-10-15T00:00:00Z
         pageStart:1
         pageEnd:17
         license:http://creativecommons.org/licenses/by-nc-nd/4.0/
         sameAs:https://doi.org/10.1186/s12951-024-02918-2
         keywords:
            Ferroptosis
            LHPP
            Gemcitabine prodrug
            miRNA inhibitor
            Biotechnology
            Nanotechnology
            Molecular Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12951-024-02918-2/MediaObjects/12951_2024_2918_Figa_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12951-024-02918-2/MediaObjects/12951_2024_2918_Sch1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12951-024-02918-2/MediaObjects/12951_2024_2918_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12951-024-02918-2/MediaObjects/12951_2024_2918_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12951-024-02918-2/MediaObjects/12951_2024_2918_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12951-024-02918-2/MediaObjects/12951_2024_2918_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12951-024-02918-2/MediaObjects/12951_2024_2918_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12951-024-02918-2/MediaObjects/12951_2024_2918_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12951-024-02918-2/MediaObjects/12951_2024_2918_Fig7_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12951-024-02918-2/MediaObjects/12951_2024_2918_Fig8_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12951-024-02918-2/MediaObjects/12951_2024_2918_Fig9_HTML.png
         isPartOf:
            name:Journal of Nanobiotechnology
            issn:
               1477-3155
            volumeNumber:22
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Yang Qin
               affiliation:
                     name:University of South China
                     address:
                        name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xiaoli Ling
               affiliation:
                     name:University of South China
                     address:
                        name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yunxian Li
               affiliation:
                     name:University of South China
                     address:
                        name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jieqiong Wang
               affiliation:
                     name:University of South China
                     address:
                        name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jiaqi Wang
               affiliation:
                     name:University of South China
                     address:
                        name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zhuoyi Rong
               affiliation:
                     name:University of South China
                     address:
                        name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yao Cheng
               affiliation:
                     name:University of South China
                     address:
                        name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zhenghao Tao
               affiliation:
                     name:University of South China
                     address:
                        name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Haitao Zhang
               affiliation:
                     name:University of South China
                     address:
                        name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Hua Wei
               affiliation:
                     name:University of South China
                     address:
                        name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Cui-Yun Yu
               affiliation:
                     name:University of South China
                     address:
                        name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
                        type:PostalAddress
                     type:Organization
                     name:Affiliated Hospital of Hunan Academy of Chinese Medicine, Hunan Academy of Chinese Medicine
                     address:
                        name:Affiliated Hospital of Hunan Academy of Chinese Medicine, Hunan Academy of Chinese Medicine, Changsha, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Histidine phosphatase-ferroptosis crosstalk modulation for efficient hepatocellular carcinoma treatment
      description:Altering the mechanisms of tumor cell death and overcoming the limitations of traditional chemotherapy is pivotal to contemporary tumor treatment. Inducing ferroptosis, while circumventing safety concerns associated with ferrous vectors, through nonferrous ferroptosis is a promising but underexplored frontier in cancer therapy. Histidine phosphatase (LHPP) has emerged as a novel therapeutic target in treating hepatocellular carcinoma (HCC), but the precise mechanism of LHPP against HCC remains unclear. Herein, we explore the effects of upregulating LHPP expression on ferroptosis and tumor immunogenicity induction by simply delivering a miRNA-363-5p inhibitor (miR-363-5pi) via a previously optimized gemcitabine-oleic acid (GOA) prodrug. Efficient miRNA encapsulation was achieved through hydrogen bonding at an optimized GOA/miRNA molar feed ratio of 250:1, affording spherical nanoparticles with a uniform hydrodynamic size of 147.1 nm and a negative potential of -21.5 mV. The mechanism of this LHPP-ferroptosis crosstalk is disclosed to be an inhibited phosphorylation of the PI3K/Akt pathway, leading to a remarkable tumor inhibition rate of 88.2% in nude mice bearing Bel-7402 tumor xenografts via a combination of LHPP-triggered nonferrous ferroptosis and GOA-induced chemotherapy. The biocompatibility of GOA/miR-363-5pi is strongly supported by their non-hematologic toxicity and insignificant organ damage. In addition, the tumor immunogenic activation potential of GOA/miR-363-5pi was finally explored. Overall, this study is the first work that elucidates the precise mechanism of LHPP for treating HCC via ferroptosis induction and achieves the transformation of chemotherapy and gene therapy into ferroptosis activation with tumor cell immunogenicity, which lays a new therapeutic foundation for the clinical treatment of HCC.
      datePublished:2024-10-15T00:00:00Z
      dateModified:2024-10-15T00:00:00Z
      pageStart:1
      pageEnd:17
      license:http://creativecommons.org/licenses/by-nc-nd/4.0/
      sameAs:https://doi.org/10.1186/s12951-024-02918-2
      keywords:
         Ferroptosis
         LHPP
         Gemcitabine prodrug
         miRNA inhibitor
         Biotechnology
         Nanotechnology
         Molecular Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12951-024-02918-2/MediaObjects/12951_2024_2918_Figa_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12951-024-02918-2/MediaObjects/12951_2024_2918_Sch1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12951-024-02918-2/MediaObjects/12951_2024_2918_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12951-024-02918-2/MediaObjects/12951_2024_2918_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12951-024-02918-2/MediaObjects/12951_2024_2918_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12951-024-02918-2/MediaObjects/12951_2024_2918_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12951-024-02918-2/MediaObjects/12951_2024_2918_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12951-024-02918-2/MediaObjects/12951_2024_2918_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12951-024-02918-2/MediaObjects/12951_2024_2918_Fig7_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12951-024-02918-2/MediaObjects/12951_2024_2918_Fig8_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12951-024-02918-2/MediaObjects/12951_2024_2918_Fig9_HTML.png
      isPartOf:
         name:Journal of Nanobiotechnology
         issn:
            1477-3155
         volumeNumber:22
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Yang Qin
            affiliation:
                  name:University of South China
                  address:
                     name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xiaoli Ling
            affiliation:
                  name:University of South China
                  address:
                     name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yunxian Li
            affiliation:
                  name:University of South China
                  address:
                     name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jieqiong Wang
            affiliation:
                  name:University of South China
                  address:
                     name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jiaqi Wang
            affiliation:
                  name:University of South China
                  address:
                     name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zhuoyi Rong
            affiliation:
                  name:University of South China
                  address:
                     name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yao Cheng
            affiliation:
                  name:University of South China
                  address:
                     name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zhenghao Tao
            affiliation:
                  name:University of South China
                  address:
                     name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Haitao Zhang
            affiliation:
                  name:University of South China
                  address:
                     name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Hua Wei
            affiliation:
                  name:University of South China
                  address:
                     name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Cui-Yun Yu
            affiliation:
                  name:University of South China
                  address:
                     name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
                     type:PostalAddress
                  type:Organization
                  name:Affiliated Hospital of Hunan Academy of Chinese Medicine, Hunan Academy of Chinese Medicine
                  address:
                     name:Affiliated Hospital of Hunan Academy of Chinese Medicine, Hunan Academy of Chinese Medicine, Changsha, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Journal of Nanobiotechnology
      issn:
         1477-3155
      volumeNumber:22
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of South China
      address:
         name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
         type:PostalAddress
      name:University of South China
      address:
         name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
         type:PostalAddress
      name:University of South China
      address:
         name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
         type:PostalAddress
      name:University of South China
      address:
         name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
         type:PostalAddress
      name:University of South China
      address:
         name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
         type:PostalAddress
      name:University of South China
      address:
         name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
         type:PostalAddress
      name:University of South China
      address:
         name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
         type:PostalAddress
      name:University of South China
      address:
         name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
         type:PostalAddress
      name:University of South China
      address:
         name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
         type:PostalAddress
      name:University of South China
      address:
         name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
         type:PostalAddress
      name:University of South China
      address:
         name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
         type:PostalAddress
      name:Affiliated Hospital of Hunan Academy of Chinese Medicine, Hunan Academy of Chinese Medicine
      address:
         name:Affiliated Hospital of Hunan Academy of Chinese Medicine, Hunan Academy of Chinese Medicine, Changsha, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Yang Qin
      affiliation:
            name:University of South China
            address:
               name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
               type:PostalAddress
            type:Organization
      name:Xiaoli Ling
      affiliation:
            name:University of South China
            address:
               name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
               type:PostalAddress
            type:Organization
      name:Yunxian Li
      affiliation:
            name:University of South China
            address:
               name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
               type:PostalAddress
            type:Organization
      name:Jieqiong Wang
      affiliation:
            name:University of South China
            address:
               name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
               type:PostalAddress
            type:Organization
      name:Jiaqi Wang
      affiliation:
            name:University of South China
            address:
               name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
               type:PostalAddress
            type:Organization
      name:Zhuoyi Rong
      affiliation:
            name:University of South China
            address:
               name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
               type:PostalAddress
            type:Organization
      name:Yao Cheng
      affiliation:
            name:University of South China
            address:
               name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
               type:PostalAddress
            type:Organization
      name:Zhenghao Tao
      affiliation:
            name:University of South China
            address:
               name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
               type:PostalAddress
            type:Organization
      name:Haitao Zhang
      affiliation:
            name:University of South China
            address:
               name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Hua Wei
      affiliation:
            name:University of South China
            address:
               name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Cui-Yun Yu
      affiliation:
            name:University of South China
            address:
               name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
               type:PostalAddress
            type:Organization
            name:Affiliated Hospital of Hunan Academy of Chinese Medicine, Hunan Academy of Chinese Medicine
            address:
               name:Affiliated Hospital of Hunan Academy of Chinese Medicine, Hunan Academy of Chinese Medicine, Changsha, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
      name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
      name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
      name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
      name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
      name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
      name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
      name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
      name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
      name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
      name:Pharmaceutical and Biomedical Polymers Research Laboratory, Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science & MOE Key Lab of Rare Pediatric Disease, Hengyang Medical School, University of South China, Hengyang, China
      name:Affiliated Hospital of Hunan Academy of Chinese Medicine, Hunan Academy of Chinese Medicine, Changsha, China

External Links {🔗}(142)

• https://www.springernature.com/gp/authors's financial summary
• https://link.springernature.com/home/'s revenue stream
• Financial intake of https://order.springer.com/public/cart
• How much money does https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research generate?
• How much does https://jnanobiotechnology.biomedcentral.com/about net monthly?
• What's the profit of https://submission.nature.com/new-submission/12951/3?
• What are the total earnings of https://doi.org/10.1016%2FS0140-6736%2818%2930010-2?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29307467 make?
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Hepatocellular%20carcinoma&journal=Lancet&doi=10.1016%2FS0140-6736%2818%2930010-2&volume=391&pages=1301-14&publication_year=2018&author=Forner%2CA&author=Reig%2CM&author=Bruix%2CJ?
• Financial intake of https://doi.org/10.1016%2Fj.jconrel.2022.05.024
• Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=35577150
• Income figures for http://scholar.google.com/scholar_lookup?&title=Prolonged%20blood%20circulation%20outperforms%20active%20targeting%20for%20nanocarriers-mediated%20enhanced%20hepatocellular%20carcinoma%20therapy%20in%20vivo&journal=J%20Control%20Release&doi=10.1016%2Fj.jconrel.2022.05.024&volume=347&pages=400-13&publication_year=2022&author=Wang%2CYQ&author=Huang%2CC&author=Ye%2CPJ&author=Long%2CJR&author=Xu%2CCH&author=Liu%2CY&author=Ling%2CXL&author=Lv%2CSY&author=He%2CDX&author=Wei%2CH&author=Yu%2CCY
• What are the earnings of https://doi.org/10.1016%2Fj.jconrel.2019.11.010?
• What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31733293?
• See how much http://scholar.google.com/scholar_lookup?&title=Encapsulated%20microRNA%20by%20gemcitabine%20prodrug%20for%20cancer%20treatment&journal=J%20Control%20Release&doi=10.1016%2Fj.jconrel.2019.11.010&volume=316&pages=317-30&publication_year=2019&author=Zhang%2CHT&author=Sun%2CJ&author=Yan%2CY&author=Cui%2CSH&author=Wang%2CH&author=Wang%2CCH&author=Qiu%2CC&author=Chen%2CX&author=Ding%2CJS&author=Qian%2CHG makes per month
• What's the financial intake of https://doi.org/10.1038%2Fs41580-020-00324-8?
• What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33495651 each month?
• How much money does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142022 make?
• Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Ferroptosis%3A%20mechanisms%2C%20biology%20and%20role%20in%20disease&journal=Nat%20Rev%20Mol%20Cell%20Biol&doi=10.1038%2Fs41580-020-00324-8&volume=22&pages=266-82&publication_year=2021&author=Jiang%2CX&author=Stockwell%2CBR&author=Conrad%2CM
• What's the income of https://doi.org/10.1038%2Fs41571-020-00462-0?
• Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33514910
• Find out how much http://scholar.google.com/scholar_lookup?&title=Broadening%20horizons%3A%20the%20role%20of%20ferroptosis%20in%20cancer&journal=Nat%20Rev%20Clin%20Oncol&doi=10.1038%2Fs41571-020-00462-0&volume=18&pages=280-96&publication_year=2021&author=Chen%2CX&author=Kang%2CR&author=Kroemer%2CG&author=Tang%2CD earns monthly
• Get to know what's the income of https://doi.org/10.1038%2Fs41422-020-00441-1
• What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33268902?
• How much profit is http://scholar.google.com/scholar_lookup?&title=Ferroptosis%3A%20molecular%20mechanisms%20and%20health%20implications&journal=Cell%20Res&doi=10.1038%2Fs41422-020-00441-1&volume=31&pages=107-25&publication_year=2021&author=Tang%2CD&author=Chen%2CX&author=Kang%2CR&author=Kroemer%2CG making per month?
• Learn about the earnings of https://doi.org/10.1002%2Fanie.201510031
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26836344 income
• How much money does http://scholar.google.com/scholar_lookup?&title=Synthesis%20of%20Iron%20Nanometallic%20glasses%20and%20their%20application%20in%20Cancer%20Therapy%20by%20a%20localized%20Fenton%20Reaction&journal=Angew%20Chem%20Int%20Ed%20Engl&doi=10.1002%2Fanie.201510031&volume=55&pages=2101-6&publication_year=2016&author=Zhang%2CC&author=Bu%2CW&author=Ni%2CD&author=Zhang%2CS&author=Li%2CQ&author=Yao%2CZ&author=Zhang%2CJ&author=Yao%2CH&author=Wang%2CZ&author=Shi%2CJ generate?
• Learn how profitable https://doi.org/10.1021%2Fjacs.0c05604 is on a monthly basis
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32820914 generate?
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=Endogenous%20Labile%20Iron%20Pool-mediated%20free%20Radical%20Generation%20for%20Cancer%20Chemodynamic%20Therapy&journal=J%20Am%20Chem%20Soc&doi=10.1021%2Fjacs.0c05604&volume=142&pages=15320-30&publication_year=2020&author=Lin%2CL&author=Wang%2CS&author=Deng%2CH&author=Yang%2CW&author=Rao%2CL&author=Tian%2CR&author=Liu%2CY&author=Yu%2CG&author=Zhou%2CZ&author=Song%2CJ have monthly?
• Monthly income for https://doi.org/10.1002%2Fadma.202207174
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=36210735 net monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=Ferritin-hijacking%20nanoparticles%20spatiotemporally%20directing%20endogenous%20ferroptosis%20for%20synergistic%20anticancer%20therapy&journal=Adv%20Mater&doi=10.1002%2Fadma.202207174&volume=34&publication_year=2022&author=Zhu%2CL&author=You%2CY&author=Zhu%2CM&author=Song%2CY&author=Zhang%2CJ&author=Hu%2CJ&author=Xu%2CX&author=Xu%2CX&author=Du%2CY&author=Ji%2CJ pull in monthly?
• What is the earnings of https://doi.org/10.1038%2Fnature26140?
• How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29562234 have monthly?
• How much money does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376988 generate?
• How much does http://scholar.google.com/scholar_lookup?&title=The%20protein%20histidine%20phosphatase%20LHPP%20is%20a%20tumour%20suppressor&journal=Nature&doi=10.1038%2Fnature26140&volume=555&pages=678-82&publication_year=2018&author=Hindupur%2CSK&author=Colombi%2CM&author=Fuhs%2CSR&author=Matter%2CMS&author=Guri%2CY&author=Adam%2CK&author=Cornu%2CM&author=Piscuoglio%2CS&author=Ng%2CCKY&author=Betz%2CC pull in?
• Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=36376892
• What's the revenue for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664729?
• How much does http://scholar.google.com/scholar_lookup?&title=Long%20noncoding%20RNA%20DLGAP1-AS2%20promotes%20tumorigenesis%20and%20metastasis%20by%20regulating%20the%20Trim21%2FELOA%2FLHPP%20axis%20in%20colorectal%20cancer&journal=Mol%20Cancer&doi=10.1186%2Fs12943-022-01675-w&volume=21&publication_year=2022&author=Wang%2CX&author=Cheng%2CH&author=Zhao%2CJ&author=Li%2CJ&author=Chen%2CY&author=Cui%2CK&author=Tian%2CL&author=Zhang%2CJ&author=Li%2CC&author=Sun%2CS generate monthly?
• How much does https://doi.org/10.1038%2Fs41420-021-00657-z generate monthly?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=34608127 gross monthly?
• Income figures for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490460
• http://scholar.google.com/scholar_lookup?&title=LHPP%20suppresses%20colorectal%20cancer%20cell%20migration%20and%20invasion%20in%20vitro%20and%20in%20vivo%20by%20inhibiting%20Smad3%20phosphorylation%20in%20the%20TGF-%CE%B2%20pathway&journal=Cell%20Death%20Discov&doi=10.1038%2Fs41420-021-00657-z&volume=7&publication_year=2021&author=Hou%2CB&author=Li%2CW&author=Xia%2CP&author=Zhao%2CF&author=Liu%2CZ&author=Zeng%2CQ&author=Wang%2CS&author=Chang%2CD's financial summary
• What's the income of https://doi.org/10.1073%2Fpnas.2017152117?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33229547 generate?
• How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733797 generate monthly?
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=Oncogenic%20activation%20of%20PI3K-AKT-mTOR%20signaling%20suppresses%20ferroptosis%20via%20SREBP-mediated%20lipogenesis&journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&doi=10.1073%2Fpnas.2017152117&volume=117&pages=31189-97&publication_year=2020&author=Yi%2CJ&author=Zhu%2CJ&author=Wu%2CJ&author=Thompson%2CCB&author=Jiang%2CX
• Earnings of https://doi.org/10.3389%2Ffphar.2023.1168458
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=37168995 generate monthly?
• Find out how much http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164976 earns monthly
• How much money does http://scholar.google.com/scholar_lookup?&title=Emerging%20role%20of%20ferroptosis-related%20circular%20RNA%20in%20tumor%20metastasis&journal=Front%20Pharmacol&doi=10.3389%2Ffphar.2023.1168458&volume=14&publication_year=2023&author=Meng%2CY&author=Cao%2CJ&author=Li%2CY&author=Duan%2CS&author=Zhou%2CZ&author=Li%2CJ&author=Ousmane%2CD&author=Ou%2CC&author=Wang%2CJ make?
• How much profit does https://doi.org/10.1002%2Fjcla.23071 make?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31693242's financial summary
• http://scholar.google.com/scholar_lookup?&title=Clinical%20value%20of%20LHPP-associated%20microRNAs%20combined%20with%20protein%20induced%20by%20vitamin%20K%20deficiency%20or%20antagonist-II%20in%20the%20diagnosis%20of%20alpha-fetoprotein-negative%20hepatocellular%20carcinoma&journal=J%20Clin%20Lab%20Anal&doi=10.1002%2Fjcla.23071&volume=34&publication_year=2020&author=Tian%2CZ&author=Yu%2CT&author=Wei%2CH&author=Ning%2CN income
• https://doi.org/10.1016%2Fj.tig.2022.02.006's revenue stream
• Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=35303998
• How profitable is http://scholar.google.com/scholar_lookup?&title=Emerging%20concepts%20of%20miRNA%20therapeutics%3A%20from%20cells%20to%20clinic&journal=Trends%20Genet&doi=10.1016%2Fj.tig.2022.02.006&volume=38&pages=613-26&publication_year=2022&author=Diener%2CC&author=Keller%2CA&author=Meese%2CE?
• How much does https://doi.org/10.1038%2Fnrd.2016.246 gross monthly?
• What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28209991?
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=MicroRNA%20therapeutics%3A%20towards%20a%20new%20era%20for%20the%20management%20of%20cancer%20and%20other%20diseases&journal=Nat%20Rev%20Drug%20Discov&doi=10.1038%2Fnrd.2016.246&volume=16&pages=203-22&publication_year=2017&author=Rupaimoole%2CR&author=Slack%2CFJ?
• What is the monthly revenue of https://doi.org/10.1126%2Fsciadv.abk0011?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=35353555 bring in each month?
• What's the monthly money flow for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967232?
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Stem%20cell-homing%20hydrogel-based%20miR-29b-5p%20delivery%20promotes%20cartilage%20regeneration%20by%20suppressing%20senescence%20in%20an%20osteoarthritis%20rat%20model&journal=Sci%20Adv&doi=10.1126%2Fsciadv.abk0011&volume=8&publication_year=2022&author=Zhu%2CJ&author=Yang%2CS&author=Qi%2CY&author=Gong%2CZ&author=Zhang%2CH&author=Liang%2CK&author=Shen%2CP&author=Huang%2CYY&author=Zhang%2CZ&author=Ye%2CW?
• How much profit is https://doi.org/10.1016%2Fj.jconrel.2019.10.047 making per month?
• Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31672625
• How much does http://scholar.google.com/scholar_lookup?&title=Reprogramming%20the%20T%20cell%20response%20to%20cancer%20by%20simultaneous%2C%20nanoparticle-mediated%20PD-L1%20inhibition%20and%20immunogenic%20cell%20death&journal=J%20Control%20Release&doi=10.1016%2Fj.jconrel.2019.10.047&volume=315&pages=126-38&publication_year=2019&author=Phung%2CCD&author=Nguyen%2CHT&author=Choi%2CJY&author=Pham%2CTT&author=Acharya%2CS&author=Timilshina%2CM&author=Chang%2CJH&author=Kim%2CJH&author=Jeong%2CJH&author=Ku%2CSK generate monthly?
• How much cash flow does https://doi.org/10.1021%2Facsami.9b00634 have monthly?
• Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30802029 is on a monthly basis
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=Delivery%20of%20liver-specific%20miRNA-122%20using%20a%20targeted%20Macromolecular%20Prodrug%20toward%20Synergistic%20Therapy%20for%20Hepatocellular%20Carcinoma&journal=ACS%20Appl%20Mater%20Interfaces&doi=10.1021%2Facsami.9b00634&volume=11&pages=10578-88&publication_year=2019&author=Ning%2CQ&author=Liu%2CYF&author=Ye%2CPJ&author=Gao%2CP&author=Li%2CZP&author=Tang%2CSY&author=He%2CDX&author=Tang%2CSS&author=Wei%2CH&author=Yu%2CCY
• How much does https://doi.org/10.1021%2Facsnano.5b03184 earn?
• How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26256227 generate?
• What's the monthly income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681865?
• How much does http://scholar.google.com/scholar_lookup?&title=Physical%20principles%20of%20Nanoparticle%20Cellular%20endocytosis&journal=ACS%20Nano&doi=10.1021%2Facsnano.5b03184&volume=9&pages=8655-71&publication_year=2015&author=Zhang%2CS&author=Gao%2CH&author=Bao%2CG earn?
• What's the income generated by https://doi.org/10.1016%2Fj.jconrel.2010.01.036 each month?
• Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20226220
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902597's total income per month
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Endocytosis%20of%20nanomedicines&journal=J%20Control%20Release&doi=10.1016%2Fj.jconrel.2010.01.036&volume=145&pages=182-95&publication_year=2010&author=Sahay%2CG&author=Alakhova%2CDY&author=Kabanov%2CAV
• What is the earnings of https://doi.org/10.1038%2Fnbt.2612?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23792630's revenue stream
• Income figures for http://scholar.google.com/scholar_lookup?&title=Image-based%20analysis%20of%20lipid%20nanoparticle-mediated%20siRNA%20delivery%2C%20intracellular%20trafficking%20and%20endosomal%20escape&journal=Nat%20Biotechnol&doi=10.1038%2Fnbt.2612&volume=31&pages=638-46&publication_year=2013&author=Gilleron%2CJ&author=Querbes%2CW&author=Zeigerer%2CA&author=Borodovsky%2CA&author=Marsico%2CG&author=Schubert%2CU&author=Manygoats%2CK&author=Seifert%2CS&author=Andree%2CC&author=St%C3%B6ter%2CM
• Financial intake of https://doi.org/10.1038%2Fs41565-021-00858-8
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33712737 net monthly?
• Monthly income for http://scholar.google.com/scholar_lookup?&title=Key%20principles%20and%20methods%20for%20studying%20the%20endocytosis%20of%20biological%20and%20nanoparticle%20therapeutics&journal=Nat%20Nanotechnol&doi=10.1038%2Fs41565-021-00858-8&volume=16&pages=266-76&publication_year=2021&author=Rennick%2CJJ&author=Johnston%2CAPR&author=Parton%2CRG
• How much does https://doi.org/10.1038%2Fs41467-021-23902-6 earn?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=34131139 generate monthly?
• How much income does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206155 have?
• What's http://scholar.google.com/scholar_lookup?&title=iPLA2%CE%B2-mediated%20lipid%20detoxification%20controls%20p53-driven%20ferroptosis%20independent%20of%20GPX4&journal=Nat%20Commun&doi=10.1038%2Fs41467-021-23902-6&volume=12&publication_year=2021&author=Chen%2CD&author=Chu%2CB&author=Yang%2CX&author=Liu%2CZ&author=Jin%2CY&author=Kon%2CN&author=Rabadan%2CR&author=Jiang%2CX&author=Stockwell%2CBR&author=Gu%2CW's gross income?
• How much does https://doi.org/10.1021%2Facs.jmedchem.3c01749 rake in every month?
• What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=38306267?
• Explore the financials of http://scholar.google.com/scholar_lookup?&title=Ferroptosis-based%20therapeutic%20strategies%20toward%20Precision%20Medicine%20for%20Cancer&journal=J%20Med%20Chem&doi=10.1021%2Facs.jmedchem.3c01749&volume=67&pages=2238-63&publication_year=2024&author=Shi%2CTM&author=Chen%2CXF&author=Ti%2CH
• https://doi.org/10.1080%2F10715762.2021.2024816's revenue stream
• Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=35038953
• Explore the financials of http://scholar.google.com/scholar_lookup?&title=MicroRNA-1287-5p%20promotes%20ferroptosis%20of%20osteosarcoma%20cells%20through%20inhibiting%20GPX4&journal=Free%20Radic%20Res&doi=10.1080%2F10715762.2021.2024816&volume=55&pages=1119-29&publication_year=2021&author=Xu%2CZ&author=Chen%2CL&author=Wang%2CC&author=Zhang%2CL&author=Xu%2CW
• Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=37461104
• What's the income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351131?
• How much income does http://scholar.google.com/scholar_lookup?&title=Exosome-mediated%20mir-144-3p%20promotes%20ferroptosis%20to%20inhibit%20osteosarcoma%20proliferation%2C%20migration%2C%20and%20invasion%20through%20regulating%20ZEB1&journal=Mol%20Cancer&doi=10.1186%2Fs12943-023-01804-z&volume=22&publication_year=2023&author=Jiang%2CM&author=Jike%2CY&author=Liu%2CK&author=Gan%2CF&author=Zhang%2CK&author=Xie%2CM&author=Zhang%2CJ&author=Chen%2CC&author=Zou%2CX&author=Jiang%2CX have?
• Financial intake of https://citation-needed.springer.com/v2/references/10.1186/s12951-024-02918-2?format=refman&flavour=references
• Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yang%20Qin
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yang%20Qin%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
• What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Xiaoli%20Ling?
• What's the monthly money flow for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Xiaoli%20Ling%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yunxian%20Li bring in?
• How much income does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yunxian%20Li%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have?
• What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jieqiong%20Wang?
• What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jieqiong%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's the revenue for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jiaqi%20Wang?
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jiaqi%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
• Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Zhuoyi%20Rong earns monthly
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Zhuoyi%20Rong%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yao%20Cheng?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yao%20Cheng%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Zhenghao%20Tao income
• Income figures for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Zhenghao%20Tao%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What's the monthly money flow for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Haitao%20Zhang?
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Haitao%20Zhang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's financial summary
• What's the monthly income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hua%20Wei?
• Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hua%20Wei%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Cui-Yun%20Yu generate?
• What's the monthly money flow for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Cui-Yun%20Yu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's the total monthly financial gain of https://static-content.springer.com/esm/art%3A10.1186%2Fs12951-024-02918-2/MediaObjects/12951_2024_2918_MOESM1_ESM.docx?
• How much cash flow does http://creativecommons.org/licenses/by-nc-nd/4.0/ have monthly?
• What's the total monthly financial gain of https://s100.copyright.com/AppDispatchServlet?title=Histidine%20phosphatase-ferroptosis%20crosstalk%20modulation%20for%20efficient%20hepatocellular%20carcinoma%20treatment&author=Yang%20Qin%20et%20al&contentID=10.1186%2Fs12951-024-02918-2©right=The%20Author%28s%29&publication=1477-3155&publicationDate=2024-10-15&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY-NC-ND?
• Get to know what's the income of https://crossmark.crossref.org/dialog/?doi=10.1186/s12951-024-02918-2
• How much does https://citation-needed.springer.com/v2/references/10.1186/s12951-024-02918-2?format=refman&flavour=citation generate monthly?
• https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral income
• How much does https://www.springernature.com/gp/products pull in monthly?
• What's the revenue for https://www.springernature.com/gp/librarians?
• How much does https://www.springernature.com/gp/societies make?
• What's the total monthly financial gain of https://www.springernature.com/gp/partners?
• How much does https://www.springer.com/ earn?
• How much revenue does https://www.nature.com/ generate?
• How much revenue does https://www.biomedcentral.com/ bring in?
• How much does https://www.palgrave.com/ rake in every month?
• How much does https://www.apress.com/ earn?
• Financial intake of https://www.springernature.com/gp/legal/ccpa
• What's https://www.springernature.com/gp/info/accessibility's gross income?
• How much does https://support.springernature.com/en/support/home pull in?
• Earnings of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations
• Income figures for https://www.springernature.com/

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Particles.js
• Prism.js

CDN Services {📦}

• Crossref